Drug Type Interferons |
Synonyms interferon alfa-2b, Interferon alfa-2b (Merck Sharp & Dohme), 干扰素α-2b(默沙东) + [7] |
Target |
Action agonists, stimulants, inducers |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (04 Jun 1986), |
RegulationOrphan Drug (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02745 | INTERFERON ALFA-2B(Merck Sharp & Dohme ) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Carcinoid Tumor | European Union | 09 Mar 2000 | |
Carcinoid Tumor | Iceland | 09 Mar 2000 | |
Carcinoid Tumor | Liechtenstein | 09 Mar 2000 | |
Carcinoid Tumor | Norway | 09 Mar 2000 | |
Multiple Myeloma | European Union | 09 Mar 2000 | |
Multiple Myeloma | Iceland | 09 Mar 2000 | |
Multiple Myeloma | Liechtenstein | 09 Mar 2000 | |
Multiple Myeloma | Norway | 09 Mar 2000 | |
Philadelphia chromosome positive chronic myelogenous leukemia | European Union | 09 Mar 2000 | |
Philadelphia chromosome positive chronic myelogenous leukemia | Iceland | 09 Mar 2000 | |
Philadelphia chromosome positive chronic myelogenous leukemia | Liechtenstein | 09 Mar 2000 | |
Philadelphia chromosome positive chronic myelogenous leukemia | Norway | 09 Mar 2000 | |
Hepatitis C | China | 27 Oct 1999 | |
Kaposi Sarcoma | China | 27 Oct 1999 | |
AIDS-related Kaposi Sarcoma | United States | 04 Jun 1986 | |
Condylomata Acuminata | United States | 04 Jun 1986 | |
Follicular Lymphoma | United States | 04 Jun 1986 | |
Hairy Cell Leukemia | United States | 04 Jun 1986 | |
Hepatitis B, Chronic | United States | 04 Jun 1986 | |
Hepatitis C, Chronic | United States | 04 Jun 1986 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma, Cutaneous Malignant | Phase 3 | - | 05 Aug 1998 | |
Hutchinson's Melanotic Freckle | Phase 1 | United States | 10 Mar 2009 | |
Acquired Immunodeficiency Syndrome | Phase 1 | United States | 31 Aug 2001 |
Not Applicable | - | Interferon alpha-2b (IFN-α2b) eye drops | qhfsmahbin(thmlqpofuz) = uglfewmhko pecjmfnplz (wxggkuynqq ) View more | Positive | 22 Feb 2024 | ||
qhfsmahbin(thmlqpofuz) = pbfyncwkpb pecjmfnplz (wxggkuynqq ) View more | |||||||
Not Applicable | - | Recombinant Interferon alpha 2b (IFNα2b) 3 million international units (IU) in 0.5 mL | liwachdvot(snwzkzxbtk) = post- injection flu like illness for 2 days adzblcampx (gcsdvbislf ) | - | 23 Feb 2023 | ||
Phase 2 | 19 | wkebdjkrbv(qopkvmgome) = aqbpzqgkjt szugyeqzgd (bkkekyriyi, 13.79) View more | - | 02 Mar 2022 | |||
Phase 2/3 | 126 | (PEG-Intron) | whqudgwpdw(mehqcqmyqk) = aiivzklwyf tktaayjdbu (iptvdzutde, qtpeevckex - xmrblkktcy) View more | - | 24 Jul 2019 | ||
(INTRON A) | whqudgwpdw(mehqcqmyqk) = urqsmyaqjg tktaayjdbu (iptvdzutde, qqoaynnonh - fhhdwclaeo) View more | ||||||
Not Applicable | 34 | vwcjarlehl(kprzptkxje) = hwutzajepe wvmkmttchi (fwnswdxayv, yitgajefpc - ywooihldle) View more | - | 02 Nov 2018 | |||
Phase 2 | 38 | Recombinant Interferon Alfa-2b+Dacarbazine | uslbxcszpi = jjozewmxkx ncohbivuai (mzxpfjheul, rvdknlawmd - adjuiegoee) View more | - | 29 Oct 2018 | ||
Not Applicable | Neoplasms Adjuvant | 39 | Topical interferon alpha-2b | vhmdghhkgo(trsbqkyeql) = qufoxuekax gflbpbzbrt (moilriabsp ) View more | Positive | 01 Jul 2018 | |
vhmdghhkgo(trsbqkyeql) = ndrddxsgim gflbpbzbrt (moilriabsp ) View more | |||||||
Phase 1 | Neoadjuvant | 30 | pembrolizumab+IFN-α2b | xeikcdkrjt(iuvohvsbii) = 4 events (↑CPK, hyperglycemia, lymphocyte count decreased) xvzoipbxhi (vozuvertou ) View more | Positive | 25 Jan 2018 | |
Phase 1 | 35 | AdVTMM2 DC vaccine | hmhrqvfdte(lomsougipa) = Patients previously treated with α-CTLA-4 with/without α-PD-1 therapy had more tumor-specific IFN- γ-producing T cells before and after vaccination compared to patients that received no prior checkpoint blockade cawwqbgjpr (ucfgrmebwe ) View more | Positive | 07 Nov 2017 | ||
Phase 2 | 231 | Autologous Hemopoietic Stem Cell Transplant 1+etoposide+Maintenance+High-Dose cyclophosphamide+cisplatin+VAD+dexamethasone+cytarabine | exwdvafaui = skejhuawpg elpzsytphd (cayktchnyd, ghksfvbaun - tsnjvnuwhs) View more | - | 20 Sep 2016 |